Europe — EMA
Imesol (Etoricoxib)
GNH USA supplies Imesol (Etoricoxib), a COX‑2 inhibitor for osteoarthritis, rheumatoid arthritis and acute pain. Request a quote for global supply.
Request sourcing
What is Etoricoxib?
Etoricoxib, the active ingredient in Imesol, is a COX-2 inhibitor presented as an oral formulation for systemic use. It is indicated for the management of inflammatory joint disorders and acute pain in adult patients.
GNH USA supplies Imesol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Etoricoxib used for?
Imesol (etoricoxib) belongs to the COX‑2 selective NSAID class and is used to treat inflammatory and painful musculoskeletal conditions. - Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: alleviates inflammation and joint swelling. - Ankylosing spondylitis: diminishes spinal stiffness and pain. - Acute pain: provides rapid analgesia for short‑term severe pain. - Dental pain: controls postoperative dental discomfort.
What are the side effects of Etoricoxib?
Adverse reactions may vary in frequency and severity.
Common Side Effects: - Gastrointestinal discomfort: mild nausea, dyspepsia, or abdominal pain. - Headache: transient tension‑type headaches. - Edema: peripheral swelling, especially of the lower limbs.
Serious or Rare Side Effects: - Cardiovascular thrombotic events: increased risk of myocardial infarction or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Gastrointestinal ulcer or bleeding: serious bleeding in the stomach or intestines.
What precautions apply to Etoricoxib?
Patients should be evaluated for individual risk factors before initiating therapy. - Cardiovascular risk assessment: consider history of heart disease before use. - Blood pressure monitoring: check regularly during treatment. - Renal and hepatic function: evaluate baseline labs and monitor periodically. - Elderly caution: start at the lowest effective dose and monitor for adverse effects. - Hypersensitivity avoidance: discontinue if signs of allergic reaction appear. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.
What does Etoricoxib interact with?
Etoricoxib may interact with other medicines, altering efficacy or safety.
Major Interactions (Avoid): - Warfarin: increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal and cardiovascular toxicity. - Anticoagulants (e.g., dabigatran): potential for severe bleeding. - Lithium: elevated lithium serum concentrations.
Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Diuretics: risk of renal function decline. - Methotrexate: may increase methotrexate levels and toxicity.



